Venus Remedies secures Ukrainian GMP renewal

22 May 2025 Evaluate

Venus Remedies has successfully renewed its Good Manufacturing Practices (GMP) certification from Ukraine's State Service on Medicines and Drugs Control (SMDC). The certification applies to the company's Unit-II manufacturing facility located in Baddi, Himachal Pradesh, covering its cephalosporin, non-cephalosporin (carbapenem), and oncology parenteral production lines, including liquid and lyophilized injections. 

Renewal of the Ukrainian GMP certification underlines the company’s unwavering commitment to maintaining world-class manufacturing standards. This milestone not only reinforces its foothold in the Ukrainian market but also facilitates deeper penetration into PIC/S markets, significantly enhancing its international growth prospects.

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.


Venus Remedies Share Price

756.30 -10.70 (-1.40%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×